Metraipolis › archive › dc_7784cbc9737c

The molecular classification ushers in a new era for the treatment of advanced and recurrent endometrial cancer — Europe PMC PMID:41602382

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41602382
DOI
10.3389/fonc.2025.1761159
License (as archived)
solo-consultazione
Archived
2026-11-06T21:16:54.812Z
SHA-256 of the archived text
100f17b54d30a3b178130e409e39b7d70ff598d4342dcb58d05a7d40edd97c8b
Stable URL of this page
https://metraipolis.com/documento/dc_7784cbc9737c

How to cite

The molecular classification ushers in a new era for the treatment of advanced and recurrent endometrial cancer — Europe PMC PMID:41602382 — Europe PMC (en), https://europepmc.org/article/MED/41602382 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7784cbc9737c (Metraipolis archive dc_7784cbc9737c, sha256 100f17b54d30a3b178130e409e39b7d70ff598d4342dcb58d05a7d40edd97c8b)
BibTeX
@misc{dc7784cbc9737c,
  title = {The molecular classification ushers in a new era for the treatment of advanced and recurrent endometrial cancer — Europe PMC PMID:41602382},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41602382},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7784cbc9737c; sha256 100f17b54d30a3b178130e409e39b7d70ff598d4342dcb58d05a7d40edd97c8b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41602382. Agents can read the archived copy with the MCP tool read_document.